MedTrace Logo

Assessment Of Liver Function in Patients Undergoing Hepatic Irradiation

NCT01519219 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 208

Last updated 2020-05-20

No results posted yet for this study

Summary

The goal of the trial is to assess the effect of radiation treatment on liver function as determined by indocyanine green extraction. The long term goal is to determine if individual assessment of liver function using the IC-Green method, either alone or in combination with other factors, will provide Radiation Induced Liver Disease (RILD) risk-estimates that are superior to the probabilistic method currently in use.

Conditions

  • Hepatic Irradiation

Interventions

RADIATION

Hepatic Irradiation

Patients who take part in this study are required to be scheduled for hepatic irradiation. For the purposes of this research, they will undergo IC-GREEN testing within 2 weeks prior to the start of radiation therapy

Sponsors & Collaborators

  • University of Michigan Rogel Cancer Center

    lead OTHER

Principal Investigators

  • Theodore Lawrence, MD, PhD · University of Michigan Rogel Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-11-24
Primary Completion
2019-09-04
Completion
2020-02-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01519219 on ClinicalTrials.gov